CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule

Read the official FDA notice

Published
29 Apr 2026
Units affected
5,101 cartons
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Brand / company
Teva Pharmaceuticals USA, Inc
Codes / lots
Lots#: 100067507, 100067508, Exp 07/31/2026
Distribution
Nationwide in the USA, Puerto Rico and Virgin Islands
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.